Regulatory strategy that supports momentum, not rework
Regulatory strategy isn’t something you save for the week before an agency meeting or a major submission. It’s leadership you need at the moments that matter. We partner with biotech teams to bring senior regulatory direction into the decisions that shape development, timelines, and confidence, so regulatory thinking supports momentum rather than creating friction.
Our approach is built for biotech reality: lean teams, tight timelines, and constant tradeoffs. We take an integrated approach to health authority engagement by aligning clinical, nonclinical, CMC, safety/pharmacovigilance and quality inputs across the lifecycle, from concept to commercialization. The goal is simple: de-risk key milestones without slowing down.
In Brief
- What it is: Executive-level regulatory strategy and leadership that connects strategy to real cross-functional decisions (not just deliverables).
- Who it’s for: Emerging and scaling biotechs approaching higher-stakes milestones, or feeling the gap between regulatory execution and true regulatory affairs leadership.
- What you get: Clear health authority engagement direction, earlier risk visibility, and a right-sized path to building regulatory capability.
- How we work: Flexible support (fractional, interim, embedded) designed to partner with leadership teams, not just advise from the sidelines.
When do you need regulatory leadership?
Senior regulatory leadership becomes especially valuable when major decisions are coming fast and the cost of getting it wrong is high. This kind of support is often timely when:
- There’s a leadership gap in Regulatory Affairs (no VP+/Chief, or Regulatory is “single-threaded”)
- You’re fundraising or entering diligence and need a defensible regulatory strategy, timeline, and risk view for stakeholders
- You’re 6–12 months from major health authority interactions (pre-IND planning, key FDA/EMA meetings, end-of-phase decisions)
- You’re navigating complex modalities, faster timelines, or multi-region plans
- You’re preparing for pivotal filings, launch readiness, or inspection readiness
- You need an independent regulatory voice at the CEO/board level when timelines and credibility are on the line
What does strong regulatory strategy deliver?
Strong regulatory leadership reduces uncertainty and improves decision quality. It typically shows up as:
- A strategy that aligns with company goals and helps leaders weigh tradeoffs with clarity
- Health authority engagement that is proactive and cohesive, not reactive
- A clear evidence narrative that connects development choices to regulator expectations
- Cross-functional alignment so milestones and submissions land smoothly
- Better visibility into regulatory catalysts that can affect timelines, valuation, and optionality (including accelerated pathways)
Who is this for?
Regulatory Strategy & Leadership is designed for emerging biotech leadership teams that need senior regulatory direction near the table, where strategy is set and tradeoffs are made. It’s a fit when ambition and complexity are growing faster than the regulatory function.
You might be here because you want to:
- Bring regulatory thinking into cross-functional decisions early (not retrofit it later)
- Strengthen the story you’re telling to stakeholders, both internally and externally
- Build a right-sized operating model and governance that can scale with you
- Add senior leadership bandwidth without locking into a full-time hire too soon
How SSI supports regulatory strategy and leadership
We support regulatory strategy and leadership across three core areas:
Regulatory Strategy & Roadmap
We help you define a clear regulatory path that connects the science to the decisions in front of you. This includes sequencing, tradeoffs, and risk so leaders have a roadmap they can actually use.
This includes:
- Strategy and milestone roadmap
- Risk and tradeoff framing
- Cross-functional decision alignment
Health Authority Engagement & Milestone Readiness
We plan and guide health authority engagement with an integrated view across clinical, nonclinical, and CMC. The focus is meeting-ready strategy and milestones that land cleanly.
This includes:
- Meeting strategy and preparation
- Integrated inputs across functions
- Milestone readiness and evidence story
Build & Scale Regulatory Capability
We help you build regulatory capability that fits your stage today and scales as you grow. That includes practical foundations that support consistent execution over time.
This includes:
- Operating model and governance
- Ways of working and oversight
- Foundations for scalable execution
Engagement models: fractional, interim, or embedded CHRO support
Needs change over time, so our support is designed to flex with you. Depending on what’s happening in your company right now, SSI can support as:
Fractional Chief Regulatory Officer (CHRO)
Ongoing, part-time executive-level regulatory leadership without requiring a premature full-time hire. This model gives you senior guidance on strategy, priorities, and decision-making while keeping the structure right-sized for your stage.
Interim CHRO / interim Head of Regulatory Affairs
Time-bound leadership coverage to maintain momentum during transitions, hiring gaps, or unexpected departures. We help stabilize direction, keep commitments on track, and ensure the team and partners stay aligned.
Embedded “player/coach” support
Hands-on leadership that balances strategy with practical progress. We work alongside your team to move work forward, resolve cross-functional blockers, and keep regulatory thinking close to day-to-day decisions.
Support to an existing regulatory leader stretching into CHRO scope
Targeted support for leaders stretching into CHRO-level responsibilities. This can include capability assessment, strengthening governance and ways of working, and CEO-level advising to help the function scale with confidence.
FAQ
Regulatory strategy is the plan for how you’ll generate evidence, engage health authorities, and sequence submissions so your program can move efficiently from development toward approval. In practice, it translates the science into a roadmap and helps teams make better cross-functional decisions across clinical, nonclinical, CMC, and quality.
Most teams bring in senior regulatory leadership when they’re nearing higher-stakes inflection points. A good rule of thumb is 6–12 months before major health authority interactions or pivotal development decisions. It’s also common when there’s a leadership gap, the modality or CMC is becoming more complex, or the company is moving into multi-region planning A good rule is: bring regulatory leadership in early enough to shape the plan, not just validate it.
A fractional CHRO is an executive regulatory leader who provides senior direction part-time, without requiring a full-time hire. They typically shape strategy, guide health authority engagement, oversee key milestones and submissions, and help align nonclinical, clinical and CMC decisions with regulator expectations. In many cases, they also support an internal regulatory leader who is stepping into broader scope.
Regulatory strategy is where clinical design and nonclinical and CMC reality meet regulator expectations. It influences what evidence is needed, when it’s needed, and how endpoints and study designs are framed. It also shapes how manufacturing strategy, comparability, and quality considerations affect timing, risk, and approvability. When it’s working well, regulatory strategy keeps the program coherent across functions and reduces late-stage rework.
The fundamentals are the same (a credible evidence story and an approvable dossier), but the path often differs. Interaction models and timing vary, clinical trial start processes differ, and expedited mechanisms are not identical. A strong global strategy aligns one integrated evidence narrative while being deliberate about when and how you engage each agency, and how you sequence submissions across regions.
Resource Hub: What you need to know and where to start
Explore our expert-led articles and podcasts on regulatory strategy and leadership to help you make the right decisions at the right time. We share perspectives on key milestones, common challenges, and the decisions that shape development programmes.
Articles: Short reads to help you get oriented
Listen: Regulatory — The Emerging C-Suite Leader
Regulatory isn’t just a checklist. It’s leadership.
Hosted by Debra Aub Webster, PhD and Trevor Mill, PhD, this podcast explores how biotech leaders use regulatory insight to shape clinical decisions, development strategy, and organizational direction, especially when every choice has outsized impact.
What you’ll hear: candid conversations that go beyond the “what” of regulation into the “how” and “why” of leadership: decision-making, influence, and navigating uncertainty.
Ready to de-risk your next milestone?
If you’re approaching a major milestone, or you’re feeling the gap between execution and leadership, let’s explore what right-sized regulatory strategy and leadership could look like for your company.
